ARTHRITIS ADVISORY COMMITTEE
April 11, 2000
Briefing Information
Enbrel (etanecept) License Number 1132, SBLA
Disclaimer
The statements contained in this document are those of the product's sponsor, not FDA, and FDA does not necessarily agree with the sponsor's statements. FDA has not made a final determination about the safety or effectiveness of the product described in this document